Motion Sickness
📧 Sign up to get email alerts when something new happens for Motion Sickness.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-16Clinical Trial Update: Motion Delos: An Open Label Safety and Efficacy of Tradipitant in Participants Affected by Motion Sickness [Phase 3]
Phase 3 open-label trial update on the safety and efficacy of Tradipitant for motion sickness; the study is currently active, not recruiting…
-
CLINICAL_TRIALS trial_result · 2026-01-05Clinical Trial Update: Virtual Reality in the Rehabilitation of Visually Induced Motion Sickness [NA]
A clinical trial investigating virtual reality rehabilitation for visually induced motion sickness has completed.
-
CLINICAL_TRIALS trial_result · 2025-12-29Clinical Trial Update: The Minimum Effective Dose (ED90) of Liposomal Bupivacaine for Preserving Motor Function [Phase 4]
Phase 4 trial evaluating the minimum effective dose (ED90) of liposomal bupivacaine for preserving motor function in motion sickness has bee…
-
CLINICAL_TRIALS trial_result · 2025-08-28Clinical Trial Update: Nebulizer Delivery of Intranasal Scopolamine [Phase 1]
This update reports the completion of a Phase 1 trial evaluating nebulized intranasal scopolamine for motion sickness.
-
CLINICAL_TRIALS trial_result · 2025-06-03Clinical Trial Update: Impact of Different Types of Virtual Reality Games on Motion Sickness and Ocular in Adults: A Pilot Study [NA]
A completed pilot clinical trial from He Eye Hospital evaluated how different types of virtual reality games influence motion sickness and o…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-05-09Clinical Trial Update: Motion Sifnos: A Study to Investigate the Efficacy of Tradipitant in Subjects Affected by Motion Sickness [Phase 2]
Phase 2 trial of tradipitant for motion sickness has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2025-04-04Clinical Trial Update: Motion Serifos: A Study to Investigate the Efficacy of Tradipitant in Participants Affected by Motion Sickness [Phase 3]
A Phase 3 study evaluating tradipitant for motion sickness has completed, and results were posted in 2025.
-
CLINICAL_TRIALS trial_result · 2024-12-11Clinical Trial Update: Motion Syros: A Study to Investigate the Efficacy of Tradipitant in Subjects Affected by Motion Sickness [Phase 3]
Phase 3 trial evaluating Tradipitant for motion sickness has completed and results have been posted.
-
CLINICAL_TRIALS trial_result · 2024-07-25Clinical Trial Update: The Effect of Training Given to With Hypertension [NA]
This clinical trial update notes the completion of a training intervention study in individuals with hypertension, with motion sickness list…
-
CLINICAL_TRIALS trial_result · 2024-01-31Clinical Trial Update: Gynecologic Endoscopic Surgery of Female Motion Sickness Patients [Phase 4]
Phase 4 clinical trial update related to gynecologic endoscopic surgery in motion sickness patients, completed.
-
CLINICAL_TRIALS trial_result · 2023-09-28Clinical Trial Update: Non-pharmaceutical Motion Sickness Mitigation [NA]
Clinical trial update for non-pharmaceutical motion sickness mitigation; study completed with results posted.
-
CLINICAL_TRIALS trial_result · 2023-05-06Clinical Trial Update: Prevention and Treatment of Nausea Associated With Motion Sickness in Senior Subjects [Phase 3]
Phase 3 trial evaluating prevention and treatment of nausea associated with motion sickness in senior subjects has completed.
-
CLINICAL_TRIALS trial_result · 2023-03-21Clinical Trial Update: Efficacy and Safety of DPI-386 Nasal Gel for the Prevention of Nausea and Vomiting Associated With Motion [Phase 3]
Phase 3 trial update on DPI-386 nasal gel for prevention of nausea and vomiting due to motion; study completed.
-
CLINICAL_TRIALS trial_result · 2023-01-25Clinical Trial Update: Sensory Training for Visual Motion Sickness [NA]
Completed clinical trial evaluating sensory training for dizziness and vertigo with related motion sickness; results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2021-09-17Clinical Trial Update: Nasal Gel for the Prevention of Nausea and Vomiting Associated With Motion [Phase 3]
A Phase 3 trial evaluating a nasal gel to prevent nausea and vomiting associated with motion has completed.
-
CLINICAL_TRIALS trial_result · 2020-02-17Clinical Trial Update: Nasal Gel Under Military Operational Conditions for the Prevention of Nausea Associated With Motion Sickness [Phase 3]
Phase 3 trial update on a nasal gel intended to prevent nausea from motion sickness under military operational conditions.
-
CLINICAL_TRIALS trial_result · 2020-01-07Clinical Trial Update: DPI 386 Nasal Gel for the Prevention of Nausea Associated With Motion Sickness [Phase 2, Phase 3]
Clinical trial update for DPI 386 nasal gel in prevention of nausea due to motion sickness; study phases 2 and 3 have been terminated.
-
CLINICAL_TRIALS trial_result · 2019-12-03Clinical Trial Update: Nasal Gel for the Prevention and Treatment of Nausea Associated With Motion Sickness [Phase 3]
Phase 3 clinical trial update for a nasal gel aimed at prevention and treatment of nausea associated with motion sickness.
-
CLINICAL_TRIALS trial_result · 2019-12-03Clinical Trial Update: The Prevention and Treatment of Nausea Associated With Motion Sickness [Phase 3]
Phase 3 clinical trial update for prevention and treatment of nausea associated with motion sickness has completed.
-
CLINICAL_TRIALS trial_result · 2019-09-25Clinical Trial Update: Clinical Evaluation of the Use of Ginger Extract in the Management of Motion Sickness [Phase 4]
Phase 4 trial evaluating ginger extract for motion sickness has been completed.
-
CLINICAL_TRIALS trial_result · 2019-04-19Clinical Trial Update: Study of the Safety and Efficacy of DPI-386 Nasal Gel on Ocean-Going Vessels [Phase 3]
Phase 3 study evaluating DPI-386 nasal gel for prevention and treatment of nausea associated with motion sickness; current status is unknown…
-
CLINICAL_TRIALS trial_result · 2018-05-18Clinical Trial Update: A Comparative Bioavailability and Adhesion Performance Study, Comparing a New Scopolamine Transdermal Delivery System Formulation to the Currently Established Reference Transdermal Delivery System in Healthy Adult Participants. [Phase 1]
A Phase 1 trial comparing a new scopolamine transdermal patch to the reference patch in healthy adults to evaluate bioavailability and adhes…
-
CLINICAL_TRIALS trial_result · 2018-01-17Clinical Trial Update: Pharmacokinetic and Efficacy Profile Intranasal Scopolamine Spray [Phase 2, Phase 3]
Phase 2/3 trial of intranasal scopolamine spray for motion sickness was terminated; results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2015-12-02Clinical Trial Update: Effect of Transcutaneous Vagal Nerve Stimulation on Reducing Visually Induced Motion Sickness in Healthy Volunteers [NA]
A completed clinical trial evaluated transcutaneous vagal nerve stimulation for reducing visually induced motion sickness in healthy volunte…
-
CLINICAL_TRIALS trial_result · 2015-05-07Clinical Trial Update: Levo Phencynonate Hydrochloride for the Prevention of Seasickness [Phase 2]
Phase 2 trial evaluating Levo Phencynonate Hydrochloride for the prevention of seasickness has been completed.